IL92938A - A polypeptide that has a mutagenic activity on monocytes and AND that encodes it - Google Patents

A polypeptide that has a mutagenic activity on monocytes and AND that encodes it

Info

Publication number
IL92938A
IL92938A IL9293889A IL9293889A IL92938A IL 92938 A IL92938 A IL 92938A IL 9293889 A IL9293889 A IL 9293889A IL 9293889 A IL9293889 A IL 9293889A IL 92938 A IL92938 A IL 92938A
Authority
IL
Israel
Prior art keywords
polypeptide
thr
ala
lys
gin
Prior art date
Application number
IL9293889A
Other languages
English (en)
Hebrew (he)
Other versions
IL92938A0 (en
Original Assignee
Us Commerce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26332976&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL92938(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from JP64000065A external-priority patent/JP2893112B2/ja
Priority claimed from JP1026438A external-priority patent/JP2992640B2/ja
Application filed by Us Commerce filed Critical Us Commerce
Publication of IL92938A0 publication Critical patent/IL92938A0/xx
Publication of IL92938A publication Critical patent/IL92938A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/545—IL-1

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL9293889A 1989-01-01 1989-12-31 A polypeptide that has a mutagenic activity on monocytes and AND that encodes it IL92938A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP64000065A JP2893112B2 (ja) 1989-01-01 1989-01-01 ヒト単球走化性因子活性を有するポリペプチド及びそれをコードするｄｎａ
JP1026438A JP2992640B2 (ja) 1989-02-03 1989-02-03 ヒト単球走化性因子活性を有するポリペプチド及びそれをコードするｄｎａ並びにそれらの製法

Publications (2)

Publication Number Publication Date
IL92938A0 IL92938A0 (en) 1990-09-17
IL92938A true IL92938A (en) 1998-08-16

Family

ID=26332976

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9293889A IL92938A (en) 1989-01-01 1989-12-31 A polypeptide that has a mutagenic activity on monocytes and AND that encodes it

Country Status (10)

Country Link
EP (1) EP0452391B1 (fr)
JP (1) JPH04501961A (fr)
AT (1) ATE155526T1 (fr)
AU (1) AU642399B2 (fr)
CA (1) CA2006969C (fr)
DE (1) DE69031071T2 (fr)
DK (1) DK0452391T3 (fr)
ES (2) ES2104600T3 (fr)
IL (1) IL92938A (fr)
WO (1) WO1990007863A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL92937A0 (en) 1989-01-31 1990-09-17 Us Health Human derived monocyte attracting protein,pharmaceutical compositions comprising it and dna encoding it
US5212073A (en) * 1989-05-12 1993-05-18 Genetics Institute, Inc. Process for producing human JE cytokine
US6767535B1 (en) 1989-05-12 2004-07-27 Dana-Farber Cancer Institute, Inc. Suppressing tumor formation using cells expressing JE/monocyte chemoattractant protein-1
EP0550506B1 (fr) * 1990-09-05 2002-11-20 The Heart Research Institute Limited Nouveau facteur chimiotactique
FR2669930A1 (fr) * 1990-11-29 1992-06-05 Sanofi Sa Proteine presentant une activite de type cytokine, adn recombinant, vecteur d'expression et hotes permettant son obtention.
WO1992019737A1 (fr) * 1991-05-09 1992-11-12 Dainippon Pharmaceutical Co., Ltd. Procede de preparation d'un polypeptide de facteur chimiotactique de monocyte et souche utilisee pour cette preparation
JPH0782169A (ja) * 1993-09-13 1995-03-28 Toray Ind Inc 創傷治療剤
US7265201B1 (en) 1995-06-23 2007-09-04 Millennium Pharmaceuticals, Inc. Human chemotactic cytokine
US7067117B1 (en) 1997-09-11 2006-06-27 Cambridge University Technical Services, Ltd. Compounds and methods to inhibit or augment an inflammatory response
US6989435B2 (en) 1997-09-11 2006-01-24 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
US7238711B1 (en) 1999-03-17 2007-07-03 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
WO2007021807A1 (fr) 2005-08-12 2007-02-22 Schering Corporation Fusions de mcp1
US8524217B2 (en) 2010-05-11 2013-09-03 Merck Sharp & Dohme Corp. MCP1-Ig fusion variants

Also Published As

Publication number Publication date
AU642399B2 (en) 1993-10-21
EP0452391A4 (en) 1992-06-03
CA2006969A1 (fr) 1990-07-01
AU4845090A (en) 1990-08-13
IL92938A0 (en) 1990-09-17
CA2006969C (fr) 2000-03-14
DK0452391T3 (da) 1997-10-20
DE69031071D1 (de) 1997-08-21
JPH04501961A (ja) 1992-04-09
EP0452391A1 (fr) 1991-10-23
WO1990007863A1 (fr) 1990-07-26
ATE155526T1 (de) 1997-08-15
DE69031071T2 (de) 1998-02-05
ES2056753A6 (es) 1994-10-01
EP0452391B1 (fr) 1997-07-16
ES2104600T3 (es) 1997-10-16

Similar Documents

Publication Publication Date Title
Wallner et al. Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity
CA1341240C (fr) Adn codant pour le facteur de necrose tumorale humain, ainsi qu'un polypeptide agissant comme facteur de necrose tumorale humain
DK172276B1 (da) Rekombinant derivat af human tumornekrosefaktor (hTNF), strukturelt gen, som koder for det rekombinante derivat, ekspressionsvektor, værtsceller, transformeret E. coli, fremgangsmåder til fremstilling af det rekombinante derivat og det strukturelle gen, oligonukleotid til brug ved fremstilling af genet, terapeutiske sammensætninger og formuleringer
CA2024629C (fr) Proteine morphogenique osseuse dactylethre laevis, adn l'encodant et son utilisation
US4677064A (en) Human tumor necrosis factor
EP0188920B1 (fr) Interleukine 1 et son dérivé
DK174044B1 (da) Polypeptid afledt fra human granulocytkolonistimulerende faktor, og fremgangsmåde til fremstilling deraf, DNA kodende for nævnte polypeptid, rekombinant plasmid indeholdende nævnte DNA, og mikroorganismer indeholdende nævnte rekombinante plasmid.......
Rajavashisth et al. Cloning and tissue-specific expression of mouse macrophage colony-stimulating factor mRNA.
HU193507B (en) Process for producing interferen-like pelypeptides
PL153202B1 (en) Human immune interferon.
HU196457B (en) Process for producing interferons
IL92938A (en) A polypeptide that has a mutagenic activity on monocytes and AND that encodes it
Kluve-Beckerman et al. DNA sequence evidence for polymorphic forms of human serum amyloid A (SAA)
DK168048B1 (da) Renset human interleukin-1, dets fremstilling og anvendelse i farmaceutiske praeparater
AU589919B2 (en) Human tumor necrosis factor
JPS6363199B2 (fr)
HU202922B (en) Process for producing new limphotoxin-polypeptides
US5306627A (en) Process for producing a human neutrophil chemotactic factor peptide and a recombinant expression vector for the said polypeptide
JPH06234796A (ja) 新規な白血球インターフェロン
JP2548204B2 (ja) 新生理活性ポリペプチド
EP0431042B1 (fr) Un procede de preparation d'un polypeptide de facteur chimiotactique neutrophile humain actif
JP2675294B2 (ja) ヒト腫瘍壊死因子
US5290917A (en) Modified polypeptides of IL-1α
JPH04330282A (ja) ヒト　インターロイキン１αポリペプチドをコードするＤＮＡ
JPH051800B2 (fr)

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired